Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy Procedure [NA]
The document reports a clinical trial evaluating the COMBO Endoscopy Oropharyngeal Airway for gastrointestinal endoscopy procedures, current…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
A Yonsei University-led clinical trial investigates diagnosing multiple cancers and monitoring minimal residual disease using blood-based, h…
-
CLINICAL_TRIALS other · 2025-06-25Clinical Trial Update: FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) [Phase 1]
A Phase 1 dose-escalation trial of Lu-177-labeled PNT6555 (FRONTIER) for selected solid tumors assessing safety, tolerability and dosimetry;…
-
CLINICAL_TRIALS research · 2025-06-22Clinical Trial Update: Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This trial update describes a dose-escalation and dose-expansion study of MDX2001 in patients with advanced solid tumors, currently recruiti…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: APG-2449 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial of APG-2449 in patients with advanced solid tumors is currently recruiting, including non-small cell lung cancer, esophageal…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Developing an Ecological and Tailored Nutritional Intervention to Improve Quality of Life in Esophageal Cancer Survivors [NA]
A clinical trial is developing an ecological and tailored nutritional intervention to improve quality of life for esophageal cancer survivor…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study of CDX-585 in Patients With Advanced Malignancies [Phase 1]
Phase 1 trial update showing completed enrollment and results for CDX-585 in patients with advanced solid tumors, including non-small cell l…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: Influence of Hospital Volume on Mortality and Length of Hospital Stay After Oesophageal Cancer Resection in Switzerland
This completed clinical trial assesses whether higher hospital surgical volume affects mortality and length of stay after esophageal cancer …
-
CLINICAL_TRIALS trial_result · 2025-06-13Clinical Trial Update: Efficacy and Safety Study of Multiple Doses of IMAB362 in Patients With Advanced Gastroesophageal Cancer [Phase 2]
Phase 2 study evaluating efficacy and safety of multiple doses of IMAB362 in patients with advanced gastroesophageal cancer. The trial statu…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma [NA]
This clinical trial update notes that a study evaluating adjuvant chemotherapy after total two-field lymph node dissection for thoracic esop…
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101) [Phase 3]
Phase 3 trial evaluating a PD-1 inhibitor in combination with neoadjuvant chemoradiotherapy and surgery for locally advanced esophageal squa…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Comparison of Drainage Methods in Minimally Invasive Esophagectomy (DEMURE） [NA]
Clinical trial DEMURE is evaluating drainage methods in minimally invasive esophagectomy for esophageal cancer; the study is currently recru…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers [Phase 1]
Phase 1 trial updating on the addition of Adavosertib to radiation therapy in patients with incurable esophageal and gastroesophageal juncti…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: HTL0039732 in Participants With Advanced Solid Tumours [Phase 1, Phase 2]
HTL0039732 is being evaluated in a Phase 1/2 study for multiple advanced solid tumours and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Nasal Mask Kit in Gastrointestinal Endoscopy [NA]
A completed clinical trial evaluating a nasal mask kit used during gastrointestinal endoscopy, with indications including gastric cancer, co…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery [Phase 1, Phase 2]
This update covers a Phase 1/2 trial of olaparib plus ramucirumab in patients with metastatic or locally recurrent gastric or gastroesophage…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer [Phase 2]
Phase 2 trial evaluating PG2 in combination with chemoradiation for locally advanced esophageal cancer has completed.
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: To Evaluate the Best Metric for Inspection Time During a Diagnostic and/or Surveillance Upper Gastrointestinal Endoscopy (Age ≥ 18 Years, Informed Consent), Between Total Inspection Time Versus Withdrawal Time, for the Identification of Malignant Lesions [NA]
A recruiting clinical study in adults evaluating whether total inspection time or withdrawal time during diagnostic or surveillance upper ga…
-
CLINICAL_TRIALS withdrawal · 2025-06-04Clinical Trial Update: Defining Musical Toxicity and Its Effect on Patient Well-being
A Mayo Clinic-sponsored clinical trial titled 'Defining Musical Toxicity and Its Effect on Patient Well-being' has been withdrawn from the r…
-
CLINICAL_TRIALS research · 2025-06-04Clinical Trial Update: Proton Therapy for Esophageal Cancer [NA]
A clinical trial update indicates that a proton therapy study for esophageal cancer is currently recruiting, led by Loma Linda University.
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors [Phase 1]
Phase 1 study evaluating intra-tumoral injections of vvDD-hIL2-2-RG-1 for metastatic gastric, esophageal, liver, colorectal, and peritoneal …
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer [Phase 2]
Phase 2 clinical study evaluating the efficacy and safety of paclitaxel polymeric micelles for injection in patients with taxane-resistant p…
-
CLINICAL_TRIALS research · 2025-06-02Clinical Trial Update: Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma [Phase 2, Phase 3]
This clinical trial update outlines a Phase 2/Phase 3 study evaluating the timing of minimally invasive local treatment following first-line…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Retrospective Evaluation of Nivolumab in Adjuvant Esophageal Cancer/Gastroesophageal Junction Cancer
This clinical trial update summarizes a retrospective evaluation of nivolumab as adjuvant therapy for esophageal cancer and gastroesophageal…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer [Phase 2]
This Phase 2 trial evaluates a PD-1 antibody in combination with chemoradiotherapy for oligometastatic esophageal cancer and has completed.